At #EULAR2026 we presented our work OP071 on synovial biopsy–driven therapeutic stratification in #PsoriaticArthritis.
Our preliminary data suggest that CD117+ myeloid synovitis may support IL-17/IL-23 axis targeting in selected PsA patients.
#PsA#Rheumatology#PrecisionMedicine
🚀4th edition of #Reumasport has just concluded
Challenging the paradigm: patients with rheumatic diseases are not fragile → they are trainable💪
🔥Multidisciplinary approach, exercise as therapy,real-world vision
🚀 #ReumasportStudyGroup is now launched
IG: @reumasport_official
🤔Does prior IL-17i exposure affect retention in PsA?
🌍Real-world data from the BIRRA Study Group (868 patients across 24 centres) suggest no major impact.
💡Evidence supporting IL-17i cycling in selected patients.
🔗 https://t.co/7x3M9fvblI
#PsoriaticArthritis#Rheumatology
🎙️ New podcast by EMEUNET
With Patrick Kiely, we discuss haemochromatosis arthropathy
🔎 When to suspect it
🦴 Key clinical & radiographic clues
💡 Practical take-home messages
🎧 https://t.co/9HoJkURln0
#Rheumatology#Haemochromatosis#EULAR#MedicalEducation
🎉EULAR 2025 Classification Criteria for Haemochromatosis Arthropathy
📘 Ann Rheum Dis 👉 https://t.co/juzyh7FKwr
Proud to be part of this international effort led by Patrick Kiely with amazing colleagues, @EULAR_org & patient partners.
Thanks to @EMEUNET for the opportunity! 💪
🔎 #Ultrasound as a diagnostic tool in #PMR
New study @Rheumatol_Int ➡️Bilateral subacromial-subdeltoid bursitis > 3 mm can reliably distinguish Polymyalgia Rheumatica from rotator cuff tendinopathy.
📊 Specificity: 96.3%
📊 Sensitivity: 84.2%
👉https://t.co/cAfs24ND9G
🧐Granulomatosis with polyangiitis #GPA can present as a diagnostic emergency.A multidisciplinary approach led to timely treatment despite no initial biopsy. Later confirmation: necrotizing vasculitis.Teamwork saves lives.😎
👉🏼https://t.co/mRkgaPcatV 👀
#vasculitis#rheumatology
🧠 Joint pain in C282Y homozygous patients? Think beyond OA. Think HA.
📍 MCP 2–3 involvement, hook osteophytes, early onset, and the iconic “iron fist” are now part of a validated scoring system (specificity 93.3%, sensitivity 71.4%).
🔵Poster POS0334 | #EULAR2025
Colchicine still matters in mucosal #Behçet:
📈Withdrawal led to significant ↑ in oral ulcers at 12 weeks (2.7 vs 0.9; p<0.001)
🔹Higher relapse in women
🔹Also impact on other mucocutaneous lesions.
#BehçetSyndrome#Vasculitis#Colchicine
🧠🫀From EGPA to GCA and ANCA-AAV: exciting insights from poster tours at #EULAR2025!
🧪GC-sparing, PET/CT radiomics,avacopan, OCT biomarkers & MMP-3 for PMR-mimics,vasculitis research is evolving fast.
🔍Science meets clinical relevance!
#Vasculitis#Rheumatology#EGPA#GCA#AAV
💪 Finally! At #EULAR2025, a whole session dedicated to the role of sport in RMDs 🙌
From evidence to practice, from inflammation control to pain relief, sport is medicine.
🧠 “A DMARD and a painkiller”? Yes, with data to back it.
#RheumTwitter#ExerciseIsMedicine#RMDs
🌿 An inspiring & high-impact session on #SystemicSclerosis at #EULAR2025!
From vasodilators & PAH therapy to gene modulation and CAR-T for drug-free responses.
Here’s a thread with the highlights 👇
#SSc#Vasculopathy#RheumTwitter
Digital ulcers&antifibrotic strategies
🧤Long-term use of selexipag improves SSc-DU outcomes in multicentre data
🧬Tadalafil may modulate skin fibrosis & gene expression in SSc
🧠CRISS & AI trajectories explored in SSc patients on CD19.CAR-T
#SystemicSclerosis